AstraZeneca inaugurates €135 million expansion at Dunkerque inhaler plant

AstraZeneca inaugurated a €135 million expansion at its Dunkerque site, adding a new testing laboratory, a third formulation line, a fifth assembly line, and an automated warehouse. The expansion increases capacity for inhaler production.

“We decided to make Dunkerque the global gold standard for aerosol delivery devices— which tells you how important this site is to us.”nordfranceinvest.com

• 1 source
• nordfranceinvest.comAstraZeneca inaugurates €135 million expansion for DunkerquerootnfiartgoApr 24, 2019

Summarized from public sources; check the original articles before acting on it.